Back

Statin treatment long-term prognostic impact and its association with immune-inflammatory biomarkers levels in acute heart failure with preserved ejection fraction

28 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Modifying the diverse phenotypes of heart failure Heart Failure with Preserved Ejection Fraction (HFpEF) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Konrad Stepien

Jagiellonian University Medical College, John Paul II Hospital, Krakow (Poland)

6 More presentations in this session

Presentation thumbnail
Start in ward, finish in community: in-hospital semaglutide with 30-day nurse titration for obesity-associated heart failure with preserved ejection fraction vs usual discharge care
Doctor M. Waleed (Peshawar, PK)
Abstract Slides
Presentation thumbnail
Prevalence and prognostic impact of clinical obesity in heart failure with preserved ejection fraction: a prospective, registry cohort study
Doctor J. Chen (Chongqing, CN)
Abstract Slides
Presentation thumbnail
HFpEF hospitalisations have greater post-acute care needs than HFrEF: facility discharge and composite hospital course in the NIS (2018–2022)
Doctor V. Polana (Brooklyn, US)
Presentation thumbnail
Epidemiology and clinical characteristics of heart failure with preserved ejection fraction in hypertensive patients over 60 years old: preliminary results from epidemiology and cli-hypertension
Associate Professor M. Marketou (Heraklion, GR)
Abstract Slides
Presentation thumbnail
Clinical outcomes of carvedilol versus metoprolol in patients with heart failure with preserved ejection fraction following myocardial infarction
Doctor T. Elimihele (Iowa City, US)
Abstract Slides

Access the full session

Session thumbnail
Modifying the diverse phenotypes of heart failure

The Event

Event poster

ESC Congress 2026

28 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Analysis of the dynamics and prognostic significance of inflammatory markers in patients with heart failure who underwent acute coronary syndrome and percutaneous coronary intervention
29 June 2021
thumbnail
Congress Presentation
Statins and influenza mortality: systematic review and meta-analysis.
28 August 2022
thumbnail
Congress Presentation
Total cholesterol decrease associates with higher mortality in chronic heart failure
20 May 2023
thumbnail
Congress Presentation
Two week interruption of statin therapy results in an exaggerated inflammatory phenotype in young myocardial infarction patients without standard modifiable risk factors
28 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources